Leaflet: Information for the User
Quetiapina Kern Pharma 50 mg prolonged-release tablets EFG
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
1. What Quetiapina Kern Pharma is and what it is used for
2. What you need to know before you start taking Quetiapina Kern Pharma
3. How to take Quetiapina Kern Pharma
4. Possible side effects
5. Storage of Quetiapina Kern Pharma
6. Contents of the pack and additional information
Quetiapina Kern Pharma contains a substance called quetiapine. It belongs to a group of medicines called antipsychotics. Quetiapina Kern Pharma may be used to treat several diseases, including:
When using Quetiapina Kern Pharma prolonged-release tablets to treat major depressive episodes in major depressive disorder, this will be taken in addition to another medicine that is being used to treat this disease.
Your doctor may continue prescribing Quetiapina Kern Pharma even when you are feeling better.
Do not take Quetiapina Kern Pharma:
- some HIV medications
- azole-type medications (for fungal infections)
- erythromycin or clarithromycin (for infections)
- nefazodone (for depression).
Do not take Quetiapina Kern Pharma if the above applies to you. If you have any doubts, consult your doctor or pharmacist before taking Quetiapina Kern Pharma.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Quetiapina Kern Pharma, if:
Inform your doctor immediately if after taking Quetiapina Kern Pharma you experience any of the following:
These disorders may be caused by this type of medication.
Inform your doctor as soon as possible if you have:
Thoughts of suicide and worsening of depression
If you are depressed, you may sometimes think about harming yourself or committing suicide. This may increase at the beginning of treatment, as all these medications take time to be effective, usually around two weeks but sometimes longer. These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information obtained from clinical trials has shown an increased risk of suicidal thoughts and/or behavior in young adults under 25 with depression.
If you ever think about harming yourself or committing suicide, contact your doctor or go to the hospital immediately. It may help to tell a close family member or friend that you are depressed, and ask them to read this leaflet. You can ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behavior.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should monitor your weight regularly.
Children and adolescents
Quetiapina Kern Pharma should not be used in children and adolescents under 18 years of age.
Use of Quetiapina Kern Pharma with other medications
Inform your doctor if you are taking, have taken recently, or may need to take any other medication.
Do not take Quetiapina Kern Pharma if you are using any of the following medications:
Inform your doctor if you are using any of the following medications:
Before stopping any of your medications, consult your doctor first.
Quetiapina Kern Pharma prolonged-release tablets with food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or are planning to become pregnant, consult your doctor before using this medication.
Do not take Quetiapina Kern Pharma during pregnancy, unless your doctor has advised you to do so. Do not use Quetiapina Kern Pharma if you are breastfeeding.
The following symptoms, which may represent withdrawal syndrome, may appear in newborn babies of mothers who have used quetiapine in the last trimester (last three months of pregnancy): tremors, muscle stiffness, or weakness, drowsiness, agitation, respiratory problems, and feeding difficulties. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and operating machinery
These tablets may make you feel drowsy. Do not drive or operate tools or machinery until you know how the tablets affect you.
Quetiapina Kern Pharma prolonged-release tablets contain lactose
If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medication.
Effect on drug detection tests in urine
If you are undergoing a drug detection test in urine, taking quetiapine may produce positive results for methadone or certain antidepressant medications known as tricyclic antidepressants (TCAs) when using certain analysis methods, although you may not be taking methadone or TCAs. If this occurs, a more specific test may be performed.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again. Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your illness and your needs, but it will usually be between 150 mg and 800 mg.
Liver problems
If you have liver problems, your doctor may change your dose.
Use in elderly patients
If you are an elderly person, your doctor may change your dose.
Use in children and adolescents
Quetiapina Kern Pharma should not be used in children and adolescents under 18 years of age.
If you take more Quetiapina Kern Pharma than you should
If you take more Quetiapina Kern Pharma than your doctor prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats. Contact your doctor or the nearest hospital immediately. Bring your Quetiapina Kern Pharma tablets with you.
You can also call the Toxicological Information Service, Tf: 915620420, indicating the medication and the amount taken.
If you forget to take Quetiapina Kern Pharma
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed dose.
If you interrupt treatment with Quetiapina Kern Pharma
If you stop taking Quetiapina Kern Pharma abruptly, you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before interrupting treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
Very rare side effects(may affect up to 1 in 10,000 people):
Side effects not known(the frequency cannot be estimated from available data):
The class of medicines to which Quetiapine Kern Pharma belongs may cause serious heart rhythm problems that can be life-threatening.
Some side effects are only seen when a blood test is done. These include changes in the amount of certain fats (triglycerides and total cholesterol) or sugar in the blood, changes in the amount of thyroid hormones in the blood, increased liver enzymes, decreases in the number of certain types of blood cells, decreases in the number of red blood cells, increased creatine phosphokinase in the blood (a substance found in muscles), decreases in the amount of sodium in the blood, and increases in the amount of prolactin hormone in the blood. Increases in prolactin hormone may, in rare cases, lead to the following:
Your doctor may ask you to have blood tests from time to time.
Side effects in children and adolescents
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common side effects(may affect more than 1 in 10 people):
-Girls may not have a menstrual period or have irregular periods.
Common side effects(may affect up to 1 in 10 people):
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Quetiapina Kern Pharma does not require special conditions for conservation.
Medicines should not be thrown down the drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Quetiapina Kern Pharma
The active ingredient is quetiapine. The tablets contain 50 mg of quetiapine (as quetiapine hemifumarate).
The other components are:
Tablet core: lactose monohydrate, hypromellose, sodium chloride, povidone K-30, microcrystalline cellulose silicified (silica dioxide and microcrystalline cellulose), talc, and magnesium stearate (E572).
Tablet coating: polyvinyl alcohol, titanium dioxide (E171), macrogol (E553b), talc, iron oxide red (E172), and iron oxide yellow (E172).
Appearance of Quetiapina Kern Pharma and content of the packaging
The tablets are orange-colored, round, biconvex, film-coated, and engraved with the inscription “Q50” on one face and smooth on the other face. They are presented in PVC/PVDC/Aluminum blisters or in Alu/Alu blisters, in packs of 10 or 60 tablets.
Only some pack sizes may be commercially available.
Holder of the marketing authorization
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa – Barcelona
Spain
Responsible for manufacturing
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa - Barcelona
Spain
Last review date of this leaflet:June 2024
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.